Cannabis is a plant that has been used for medical and reckless use for thousands of years, but it was not until 1996, after cannabis was legalized for medical use in the state of California, that medical use and insight into cannabis’s medical effects really benefited. Today, cannabis oil has become a popular treatment option in Western folk medicine which has been shown to produce dramatic results in a number of serious diseases.
Here we are going to look at the underlying mechanisms of action of cannabis oils, and what clinical experience and literature say about cannabis oils is their medicinal properties in the treatment of cancer and other serious diseases.
The cannabis plant contains hundreds of active substances, but it is the 142 that are categorized as cannabinoids that account for the primary medical effect of the cannabis plant, and they do so by activating specific receptors found in large parts of the body, especially in the immune system and central nervous system.
The Organic CBD Oil UK is ready for use Cannabinoids have long been used as folk medicine due to their effect on appetite, sleep, pain and nausea and as supportive treatment for cancer, but recent knowledge shows us that the cannabinoids are also capable of affecting factors that inhibit growth and proliferation and which promote programmed cell death.
There are still major studies on people who can support the effect of cannabis oil in the treatment of cancer, but there have been so many independent reports of cancer that have had good response with the use of cannabis oil, that it is no longer possible to ignore the oil as a possible treatment option, even in difficult and long-term cases.
In other words, we know the potential effect, but we lack good statistical models that can show when the effect occurs, and the use of cannabis oil must therefore be based on clinical experience.
The endocannabinoid system
The endocannabinoid system is a receptor system found in mammals whose function is to regulate nerve, cardiovascular, digestive, immune and metabolic functions. The system has until recently been understood to consist of the receptors CB1 and CB2 and the (endo) cannabinoids which activate them. The physiological effects of the cannabinoids are mainly explained by their function in this receptor system.
But emerging research shows us that the (endo) cannabinoids have more molecular targets than these two primary receptors, for the cannabinoids ability and to bind to monoamine receptors, 5-HT1A, GPR55 and GPR119, and activate PPARs and TRPV 1 and 2 (ion channels)
Greater complexity is expected to be discovered, so the full effect of the cannabinoids on the human body can only be categorized as comprehensive and highly complex.
The system’s receptors
Four receptors have been identified: CB1, CB2, WIN and abn-cannabidiol.The CB1 receptor is mainly located in the central nervous system, and especially in various parts of the brain, but you want to find the receptor in more peripheral tissues such as uterus, ovaries, testes and prostate.
Most central nervous system effects are dependent on CB1 receptor activation.The CB2 receptor is predominantly localized in the immune system (spleen, tonsils, lymph nodes, mast cells, NK cells, macrophages and lymphocytes) where they modulate immune functions, but you also want to find the receptor elsewhere, for example, in the microglial cells located throughout the central nervous system.
